Joint Formulary & PAD

Umeclidinium with vilanterol (Anoro Ellipta) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Umeclidinium with vilanterol (Anoro Ellipta)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA LABA
Keywords :
Umeclidinium 55mcg/Vilanterol 22mcg, LAMA LABA, LAMA/LABA
Brand Names Include :
Anoro Ellipta
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
4

Committee Recommendations (1)

The locally preferred LAMA/LABA devices are as follows:

  • Spiolto Respimat (tiotropium / olodaterol soft mist inhaler). Re-usable device.
  • Anoro Ellipta (Umeclidinium / vilanterol DPI)
  • Ultibro Breezhaler (Glycopyrronium / indacaterol DPI)
  • Duaklir Genuair (Aclidinium / formoterol DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information

Other Indications

Below are listed other indications that Umeclidinium with vilanterol (Anoro Ellipta) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).